Truist initiated coverage of Banc of California with a Hold rating and $14 price target following its completed merger with PacWest Bancorp. The shares remain close to fairly valued given the merger integration risks and slower growth outlook, the analyst tells investors in a research note. The firm believes the financial and strategic merits of the completed merger are compelling, but believes the stock should trade at a discount to peers given integration risks.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BANC:
- ICU Medical to replace PacWest Bancorp in S&P 600 at open on 11/30
- Banc of California, PacWest Bancorp receive shareholder approvals for merger
- Banc of California reports Q3 adjusted EPS 30c, consensus 30c
- Banc of California Inc. (BANC) Q3 Earnings Cheat Sheet
- PacWest Bancorp, Banc of California receive final regulatory approval for merger